XML 54 R43.htm IDEA: XBRL DOCUMENT v3.25.1
Segment Reporting (Tables)
 3 Months Ended
Mar. 31, 2025
Segment Reporting [Abstract]  
Schedule of Sales Information By Reportable Segments Segment results for the three months ended March 31, 2025 and 2024 and assets as of March 31, 2025 and December 31, 2024 based on the Company’s reportable segments are as follows (in millions):
Three Months Ended March 31,North AmericaSouth AmericaEurope/Middle EastAsia/Pacific/AfricaTotal Segments
Other(1)
Total
2025
Net sales$395.6 $229.9 $1,330.5 $94.5 $2,050.5 $— $2,050.5 
Cost of goods sold
295.5 185.2 970.9 78.3 1,529.9 — 1,529.9 
Selling, general and administrative expenses
86.6 32.4 135.2 16.4 270.6 — 270.6 
Engineering expenses
33.3 10.2 70.0 2.5 116.0 — 116.0 
Income (loss) from operations
$(19.8)$2.1 $154.4 $(2.7)$134.0 $— $134.0 
Depreciation$15.2 $7.9 $35.1 $2.3 $60.5 $— $60.5 
Capital expenditures6.3 6.6 34.4 0.9 48.2 — 48.2 
2024
Net sales(2)
$601.1 $273.0 $1,706.9 $147.6 $2,728.6 $200.1 $2,928.7 
Cost of goods sold
458.2 224.1 1,199.8 117.9 2,000.0 158.9 2,158.9 
Selling, general and administrative expenses
81.5 22.4 137.7 18.2 259.8 29.6 289.4 
Engineering expenses
33.0 14.5 74.3 2.4 124.2 6.7 130.9 
Income from operations(3)
$28.4 $12.0 $295.1 $9.1 $344.6 $4.9 $349.5 
Depreciation$14.8 $8.9 $32.1 $4.0 59.8 $3.5 $63.3 
Capital expenditures16.3 15.1 60.9 0.6 92.9 2.1 95.0 

Assets
As of March 31, 2025$1,536.3 $985.2 $3,047.1 $688.2 $6,256.8 $— $6,256.8 
As of December 31, 20241,527.9 946.9 2,841.4 697.7 6,013.9 — 6,013.9 
____________________________________
(1)    “Other” represents the results for the three months ended March 31, 2024 for the majority of the Company’s Grain & Protein business which was divested on November 1, 2024. The results of the G&P business through the date of the divestiture were previously included within our North America, South America, Europe/Middle East and Asia/Pacific/Africa segments.
(2)    Of the $200.1 million of the net sales of the divested G&P business recast to “Other”, $128.5 million, $30.4 million, $22.1 million and $19.1 million were previously included within our North America, South America, Europe/Middle East and Asia/Pacific/Africa segments, respectively.
(3)    Of the $4.9 million of the income (loss) from operations of the divested G&P business recast to “Other”, $14.0 million, $4.2 million, $(12.2) million and $(1.1) million were previously included within our North America, South America, Europe/Middle East and Asia/Pacific/Africa segments, respectively.
Schedule of Reconciliation of Income from Operations from Segment to Consolidated A reconciliation from the segment information to the consolidated balances for income from operations is set forth below (in millions):
Three Months Ended March 31,
20252024
Segment income from operations$134.0 $344.6 
Other(1)
— 4.9 
Impairment charges(1.1)— 
Corporate expenses(48.1)(53.0)
Amortization of intangibles(15.3)(13.9)
Stock compensation expense(7.1)(8.0)
Restructuring and business optimization expenses
(13.0)(1.0)
Consolidated income from operations
$49.4 $273.6 
____________________________________
(1)    “Other” represents the results for the three months ended March 31, 2024 for the majority of the Company’s Grain & Protein business which was divested on November 1, 2024. The results of the G&P business through the date of the divestiture were previously included within our North America, South America, Europe/Middle East and Asia/Pacific/Africa segments.